Astria Therapeutics, Inc.
ATXS
$4.04
$0.061.51%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 33.10% | 82.35% | 74.77% | 73.40% | 8.87% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 47.57% | 203.56% | 107.62% | 110.25% | 252.11% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 33.35% | 83.77% | 75.08% | 73.84% | 10.21% |
|
|||||
Total Current Assets | 33.35% | 83.77% | 75.08% | 73.84% | 10.21% |
Net Property, Plant & Equipment | 1,308.82% | 948.64% | 764.60% | -73.95% | -61.71% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -22.46% | 133.17% | 121.69% | 104.93% | 68.47% |
Total Assets | 34.44% | 86.55% | 77.73% | 73.57% | 10.42% |
|
|||||
Total Accounts Payable | 185.53% | 12.30% | 182.39% | -7.31% | 92.01% |
Total Accrued Expenses | 38.31% | 68.50% | 146.80% | 94.76% | 26.24% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 320.67% | 182.17% | 111.02% | -71.38% | -43.47% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 65.64% | 67.60% | 148.08% | 65.92% | 27.48% |
|
|||||
Total Current Liabilities | 65.64% | 67.60% | 148.08% | 65.92% | 27.48% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | 8,473.58% | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 100.00% | 113.01% | 214.42% | 60.93% | 22.65% |
|
|||||
Common Stock & APIC | 23.37% | 40.25% | 37.70% | 37.49% | 15.14% |
Retained Earnings | -16.24% | -18.22% | -17.55% | -15.73% | -14.36% |
Treasury Stock & Other | -- | -- | -- | -250.00% | -- |
Total Common Equity | 51.52% | 176.29% | 139.59% | 134.76% | 18.41% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | -1.11% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -1.11% |
|
|||||
Total Common Equity | 51.52% | 176.29% | 139.59% | 134.76% | 18.41% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -1.11% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 31.32% | 85.20% | 73.19% | 73.99% | 9.90% |
|